European Urology Focus

Slides:

Advertisements

Similar presentations

Diana Cardona-Grau, Igor Sorokin, Gabriel Leinwand, Charles Welliver

Advertisements

Volume 57, Issue 3, Pages (March 2010)

Volume 63, Issue 1, Pages (January 2013)

European Urology Focus

Volume 187, Issue 6, Pages (June 2012)

European Urology Focus

Impact of LUTS Using Bother Index in DAN-PSS-1 Questionnaire

Volume 55, Issue 1, Pages 1-8 (January 2009)

Volume 180, Issue 3, Pages (September 2008)

Volume 164, Issue 6, Pages (December 2000)

Urologist Practice Affiliation and Intensity-modulated Radiation Therapy for Prostate Cancer in the Elderly Brent K. Hollenbeck, Samuel R. Kaufman, Phyllis.

Dietary Antioxidants and Longitudinal Changes in Lower Urinary Tract Symptoms in Elderly Men: The Osteoporotic Fractures in Men Study Kathleen F. Holton,

Volume 41, Issue 6, Pages (June 2002)

Volume 70, Issue 3, Pages (September 2016)

Economic Value of the Transurethral Resection in Saline System for Treatment of Benign Prostatic Hyperplasia in England and Wales: Systematic Review,

Volume 45, Issue 5, Pages (May 2004)

Volume 54, Issue 2, Pages (August 2008)

Volume 68, Issue 6, Pages (December 2015)

Volume 50, Issue 1, Pages (July 2006)

Volume 52, Issue 1, Pages (July 2007)

Volume 51, Issue 2, Pages (February 2007)

Volume 62, Issue 5, Pages (November 2012)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

European Urology Focus

European Urology Focus

European Urology Focus

European Urology Focus

Testosterone Therapy in Men With Prostate Cancer

David Lorente, Karim Fizazi, Christopher Sweeney, Johann S. de Bono

Volume 61, Issue 6, Pages (June 2012)

Volume 71, Issue 1, Pages (January 2017)

Volume 61, Issue 5, Pages (May 2012)

Volume 68, Issue 5, Pages (November 2015)

Volume 64, Issue 4, Pages (October 2013)

Volume 61, Issue 2, Pages (February 2012)

Volume 52, Issue 3, Pages (September 2007)

Prostate Cancer Epidemic in Sight?

Tumour Grade, Treatment, and Relative Survival in a Population-based Cohort of Men with Potentially Curable Prostate Cancer Sam Ladjevardi, Gabriel Sandblom,

Elizabeth K. Bancroft, Rosalind A. Eeles

Volume 59, Issue 4, Pages (April 2011)

Prostate Cancer Detection: A View of the Future

Volume 66, Issue 3, Pages (September 2014)

Counselling the Prostate Cancer Patient

Laurent Boccon-Gibod European Urology Supplements

Prostate Cancer Epidemic in Sight?

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 61, Issue 6, Pages (June 2012)

Volume 71, Issue 1, Pages (January 2017)

Volume 71, Issue 4, Pages (April 2017)

Physical Activity and Survival After Prostate Cancer

Is It Necessary to Detect All Prostate Cancers in Men with Serum PSA Levels

Volume 50, Issue 5, Pages (November 2006)

Anna Grenabo Bergdahl, Erik Holmberg, Sue Moss, Jonas Hugosson

CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System

Volume 53, Issue 1, Pages (January 2008)

The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.

Volume 59, Issue 4, Pages (April 2011)

Volume 65, Issue 6, Pages (June 2014)

European Urology Oncology

Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.

Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson

Counselling of the Prostate Cancer Patient as a Whole Person

Volume 51, Issue 2, Pages (February 2007)

Volume 54, Issue 3, Pages (September 2008)

Oncoforum Urology: Prostate Cancer 2008 at a Glance

Epidemiology and Demographics of Prostatitis

Does PSA Testing Influence the Natural History of Prostate Cancer?

European Urology Oncology

European Urology Oncology

Volume 76, Issue 1, Pages (July 2019)

Presentation transcript:

European Urology Focus Statin Use and Prostate Cancer Survival in the Finnish Randomized Study of Screening for Prostate Cancer Teemu J. Murtola, Antti I. Peltomaa, Kirsi Talala, Liisa Määttänen, Kimmo Taari, Teuvo L.J. Tammela, Anssi Auvinen European Urology Focus DOI: 10.1016/j.euf.2016.05.004 Copyright © 2016 European Association of Urology Terms and Conditions

Fig. 1 Definition for statin use status during the follow-up. Cohort of prostate cancer cases diagnosed among men participating in the Finnish Prostate Cancer Screening Trial during 1996–2012. (A) Statin use before prostate cancer diagnosis and (B) after prostate cancer diagnosis. PCA=prostate cancer. a Current and previous statin users also analyzed together in the category of any statin use. European Urology Focus DOI: (10.1016/j.euf.2016.05.004) Copyright © 2016 European Association of Urology Terms and Conditions